相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Acetyl-L-Carnitine Prevents Methamphetamine-Induced Structural Damage on Endothelial Cells via ILK-Related MMP-9 Activity
S. Fernandes et al.
MOLECULAR NEUROBIOLOGY (2016)
Protective effects of cholecystokinin-8 on methamphetamine-induced behavioral changes and dopaminergic neurodegeneration in mice
Hongyan Gou et al.
BEHAVIOURAL BRAIN RESEARCH (2015)
A novel dopamine D-3 receptor antagonist YQA14 inhibits methamphetamine self-administration and relapse to drug-seeking behaviour in rats
Ying Chen et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2014)
Dopamine D3 receptors contribute to methamphetamine-induced alterations in dopaminergic neuronal function: Role of hyperthermia
Michelle G. Baladi et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2014)
Neurotoxicity of methamphetamine and 3,4-methylenedioxymethamphetamine
Laura E. Halpin et al.
LIFE SCIENCES (2014)
Is brain gliosis a characteristic of chronic methamphetamine use in the human?
Junchao Tong et al.
NEUROBIOLOGY OF DISEASE (2014)
Methamphetamine and HIV-1-induced neurotoxicity: Role of trace amine associated receptor 1 cAMP signaling in astrocytes
Irma E. Cisneros et al.
NEUROPHARMACOLOGY (2014)
Prior stimulation of the endocannabinoid system prevents methamphetamine-induced dopaminergic neurotoxicity in the striatum through activation of CB2 receptors
Joelle Nader et al.
NEUROPHARMACOLOGY (2014)
CHOLECYSTOKININ OCTAPEPTIDE INDUCES ENDOGENOUS OPIOID-DEPENDENT ANXIOLYTIC EFFECTS IN MORPHINE-WITHDRAWAL RATS
D. Wen et al.
NEUROSCIENCE (2014)
Differential effects of binge methamphetamine injections on the mRNA expression of histone deacetylases (HDACs) in the rat striatum
Oluwaseyi Omonijo et al.
NEUROTOXICOLOGY (2014)
The Endocannabinoid System and the Brain
Raphael Mechoulam et al.
ANNUAL REVIEW OF PSYCHOLOGY, VOL 64 (2013)
Effects of cholecystokinin-8 on morphine-induced spatial reference memory impairment in mice
Shengchang Yang et al.
BEHAVIOURAL BRAIN RESEARCH (2013)
Inhibition of ROCK2 expression protects against methamphetamine-induced neurotoxicity in PC12 cells
Xingyi Yang et al.
BRAIN RESEARCH (2013)
Methamphetamine use: A comprehensive review of molecular, preclinical and clinical findings
William J. Panenka et al.
DRUG AND ALCOHOL DEPENDENCE (2013)
Human Immunodeficiency Virus Infection Heightens Concurrent Risk of Functional Dependence in Persons With Long-Term Methamphetamine Use
Kaitlin Blackstone et al.
JOURNAL OF ADDICTION MEDICINE (2013)
Methamphetamine-induced Occludin Endocytosis Is Mediated by the Arp2/3 Complex-regulated Actin Rearrangement
Minseon Park et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
A study on the effect of JNK inhibitor, SP600125, on the disruption of blood-brain barrier induced by methamphetamine
Andres Urrutia et al.
NEUROBIOLOGY OF DISEASE (2013)
Up-regulation of protein tyrosine nitration in methamphetamine-induced neurotoxicity through DDAH/ADMA/NOS pathway
Fu Zhang et al.
NEUROCHEMISTRY INTERNATIONAL (2013)
Perseverative behavior in rats with methamphetamine-induced neurotoxicity
Jong-Hyun Son et al.
NEUROPHARMACOLOGY (2013)
Methamphetamine-induced nitric oxide promotes vesicular transport in blood-brain barrier endothelial cells
Tania Martins et al.
NEUROPHARMACOLOGY (2013)
A role for D1 dopamine receptors in striatal methamphetamine-induced neurotoxicity
Danielle M. Friend et al.
NEUROSCIENCE LETTERS (2013)
HIV-1, Methamphetamine and Astrocyte Glutamate Regulation: Combined Excitotoxic Implications for Neuro-AIDS
Irma E. Cisneros et al.
CURRENT HIV RESEARCH (2012)
Increased risk of Parkinson's disease in individuals hospitalized with conditions related to the use of methamphetamine or other amphetamine-type drugs
Russell C. Callaghan et al.
DRUG AND ALCOHOL DEPENDENCE (2012)
Persistent Neuroinflammatory Effects of Serial Exposure to Stress and Methamphetamine on the Blood-Brain Barrier
Nicole A. Northrop et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2012)
Distinct Roles of Dopamine D3 Receptors in Modulating Methamphetamine-Induced Behavioral Sensitization and Ultrastructural Plasticity in the Shell of the Nucleus Accumbens
Jie Zhu et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2012)
METHAMPHETAMINE-INDUCED NEUROTOXICITY LINKED TO UBIQUITIN-PROTEASOME SYSTEM DYSFUNCTION AND AUTOPHAGY-RELATED CHANGES THAT CAN BE MODULATED BY PROTEIN KINASE C DELTA IN DOPAMINERGIC NEURONAL CELLS
M. Lin et al.
NEUROSCIENCE (2012)
Methamphetamine influences on brain and behavior: unsafe at any speed?
John F. Marshall et al.
TRENDS IN NEUROSCIENCES (2012)
Parkin controls dopamine utilization in human midbrain dopaminergic neurons derived from induced pluripotent stem cells
Houbo Jiang et al.
NATURE COMMUNICATIONS (2012)
The effects of psychostimulant drugs on blood brain barrier function and neuroinflammation
Sharanya M. Kousik et al.
FRONTIERS IN PHARMACOLOGY (2012)
Mitochondrial dysfunction induced by knockdown of mortalin is rescued by Parkin
Hui Yang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
Prospects for cannabinoid therapies in basal ganglia disorders
Javier Fernandez-Ruiz et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Dopamine D3 receptor antagonist SB-277011A inhibits methamphetamine self-administration and methamphetamine-induced reinstatement of drug-seeking in rats
Amanda E. Higley et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2011)
The Tale of Protein Lysine Acetylation in the Cytoplasm
Karin Sadoul et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2011)
Imaging dopamine receptors in humans with [C-11]-(+)-PHNO: Dissection of D3 signal and anatomy
Andri C. Tziortzi et al.
NEUROIMAGE (2011)
Cholecystokinin octapeptide exerts its therapeutic effects on collagen-induced arthritis by suppressing both inflammatory and Th17 responses
Qiaoxia Li et al.
RHEUMATOLOGY INTERNATIONAL (2011)
Effects of manganese on tyrosine hydroxylase (TH) activity and TH-phosphorylation in a dopaminergic neural cell line
Danhui Zhang et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2011)
Astrocytes: biology and pathology
Michael V. Sofroniew et al.
ACTA NEUROPATHOLOGICA (2010)
Amphetamine toxicities Classical and emerging mechanisms
Bryan K. Yamamoto et al.
ADDICTION REVIEWS 2 (2010)
Determination of reactive oxygen species associated with the degeneration of dopaminergic neurons during dopamine metabolism
Mayumi Yamato et al.
FREE RADICAL RESEARCH (2010)
A role for Dimethylarginine Dimethylaminohydrolase 1 (DDAH1) in mammalian development
Ross A. Breckenridge et al.
INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY (2010)
Methamphetamine Causes Mitrochondrial Oxidative Damage in Human T Lymphocytes Leading to Functional Impairment
Raghava Potula et al.
JOURNAL OF IMMUNOLOGY (2010)
Astrogliosis in CNS Pathologies: Is There A Role for Microglia?
Dan Zhang et al.
MOLECULAR NEUROBIOLOGY (2010)
Microglial and astrocytic changes in the striatum of methamphetamine abusers
Osamu Kitamura et al.
LEGAL MEDICINE (2010)
Incidence of Parkinson's Disease Among Hospital Patients with Methamphetamine-Use Disorders
Russell C. Callaghan et al.
MOVEMENT DISORDERS (2010)
Methamphetamine Self-Administration Is Associated with Persistent Biochemical Alterations in Striatal and Cortical Dopaminergic Terminals in the Rat
Irina N. Krasnova et al.
PLOS ONE (2010)
Distribution and Pharmacokinetics of Methamphetamine in the Human Body: Clinical Implications
Nora D. Volkow et al.
PLOS ONE (2010)
Microglial activation and neuroinflammation in Alzheimer's disease: a critical examination of recent history
Wolfgang J. Streit
FRONTIERS IN AGING NEUROSCIENCE (2010)
Oxidative and nitrosative stress in Parkinson's disease
Anthony H. K. Tsang et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2009)
WIN55,212-2, a cannabinoid receptor agonist, protects against nigrostriatal cell loss in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease
David A. Price et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2009)
Dopamine, vesicular transporters and dopamine receptor expression and localization in rat thymus and spleen
Fiorenzo Mignini et al.
JOURNAL OF NEUROIMMUNOLOGY (2009)
Approaches to Prevent Dopamine Quinone-Induced Neurotoxicity
Ikuko Miyazaki et al.
NEUROCHEMICAL RESEARCH (2009)
Methamphetamine Induces Dopamine D1 Receptor-Dependent Endoplasmic Reticulum Stress-Related Molecular Events in the Rat Striatum
Subramaniam Jayanthi et al.
PLOS ONE (2009)
Brain serotonin transporter in human methamphetamine users
Stephen J. Kish et al.
PSYCHOPHARMACOLOGY (2009)
Defining Neuroinflammation Lessons from MPTP- and Methamphetamine-Induced Neurotoxicity
James P. O'Callaghan et al.
DRUG ADDICTION: RESEARCH FRONTIERS AND TREATMENT ADVANCES (2008)
The role of autophagy-lysosome pathway in neurodegeneration associated with Parkinson's disease
Tianhong Pan et al.
BRAIN (2008)
Zinc rescues dopaminergic SK-N-SH cell lines from methamphetamine-induced toxicity
Amornpan Ajimaporn et al.
BRAIN RESEARCH BULLETIN (2008)
Pharmacologic mechanisms of crystal meth
Stephen J. Kish
CANADIAN MEDICAL ASSOCIATION JOURNAL (2008)
Suppression of autophagy precipitates neuronal cell death following low doses of methamphetamine
Roberta Castino et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Involvement of dopamine receptors and β-arrestin in metamphetamine-induced inclusions formation in pc12 cells
Francesco Fornai et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Methamphetamine causes microglial activation in the brains of human abusers
Yoshimoto Sekine et al.
JOURNAL OF NEUROSCIENCE (2008)
Proteomic profiling of proteins associated with methamphetamine-induced neurotoxicity in different regions of rat brain
Xuefeng Li et al.
NEUROCHEMISTRY INTERNATIONAL (2008)
Review:: Familial Parkinson's disease -: genetics, clinical phenotype and neuropathology in relation to the common sporadic form of the disease
Carola Schiesling et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2008)
Protective effects of interferon-γ against methamphetamine-induced neurotoxicity
Hiroaki Hozumi et al.
TOXICOLOGY LETTERS (2008)
rAAV-mediated nigral human parkin over-expression partially ameliorates motor deficits via enhanced dopamine neurotransmission in a rat model of Parkinson's disease
Fredric P. Manfredsson et al.
EXPERIMENTAL NEUROLOGY (2007)
Melatonin protects SK-N-SH neuroblastoma cells from amphetamine-induced neurotoxicity
Sirirat Klongpanichapak et al.
JOURNAL OF PINEAL RESEARCH (2007)
CCK-8 inhibits LPS-induced IL-1β production in pulmonary interstitial macrophages by modulating PKA, p38, and NF-κB pathway
Shujin Li et al.
SHOCK (2007)
Immunohistochemical investigation of dopaminergic terminal markers and caspase-3 activation in the striatum of human methamphetamine users
Osamu Kitamura et al.
INTERNATIONAL JOURNAL OF LEGAL MEDICINE (2007)
DJ-1 and Parkin modulate dopamine-dependent behavior and inhibit MPTP-induced nigral dopamine neuron loss in mice
Jean-Charles Paterna et al.
MOLECULAR THERAPY (2007)
Suppression of p53-activated gene, PAG608, attenuates methamphetamine-induced neurotoxicity
Masato Asanuma et al.
NEUROSCIENCE LETTERS (2007)
Protective effects of minocycline on behavioral changes and neurotoxicity in mice after administration of methamphetamine
Lin Zhang et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2006)
Parkin protects against neurotoxicity in the 6-hydroxydopamine rat model for Parkinson's disease
Linda Vercammen et al.
MOLECULAR THERAPY (2006)
Parkin: a multifaceted ubiquitin ligase
D. J. Moore
BIOCHEMICAL SOCIETY TRANSACTIONS (2006)
Involvement of DDAH/ADMA/NOS pathway in nicotine-induced endothelial dysfunction
De-Jian Jiang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Reflection impulsivity in current and former substance users
Luke Clark et al.
BIOLOGICAL PSYCHIATRY (2006)
Ubiquitin-protein ligase parkin and its role in the development of Parkinson's disease
O. A. Buneeva et al.
BIOCHEMISTRY-MOSCOW (2006)
Parkin is protective for substantia nigra dopamine neurons in a tau gene transfer neurodegeneration model
Ronald L. Klein et al.
NEUROSCIENCE LETTERS (2006)
Prostaglandin H synthase-catalyzed bioactivation of amphetamines to free radical intermediates that cause CNS regional DNA oxidation and nerve terminal degeneration
Winnie Jeng et al.
FASEB JOURNAL (2006)
Cognitive function and nigrostriatal markers in abstinent methamphetamine abusers
CE Johanson et al.
PSYCHOPHARMACOLOGY (2006)
Dopamine selectively induces migration and homing of naive CD8+ T cells via dopamine receptor D3
Y Watanabe et al.
JOURNAL OF IMMUNOLOGY (2006)
Methamphetamine-induced cell death: Selective vulnerability in neuronal subpopulations of the striatum in mice
J. P. Q. Zhu et al.
NEUROSCIENCE (2006)
Methamphetamine-induced dopaminergic neurotoxicity is regulated by quinone formation-related molecules
I Miyazaki et al.
FASEB JOURNAL (2006)
The DDAH-ADMA-NOS pathway
JM Leiper
THERAPEUTIC DRUG MONITORING (2005)
Methamphetamine-induced neuronal apoptosis involves the activation of multiple death pathways. Review.
JL Cadet et al.
NEUROTOXICITY RESEARCH (2005)
Amphetamine treatment similar to that used in the treatment of adult attention-deficit/hyperactivity disorder damages dopaminergic nerve endings in the striatum of adult nonhuman primates
GA Ricaurte et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Parkin gene therapy for α-synucleinopathy:: A rat model of Parkinson's disease
M Yamada et al.
HUMAN GENE THERAPY (2005)
Cannabinoid receptors and their role in neuroprotection
M van der Stelt et al.
NEUROMOLECULAR MEDICINE (2005)
Calcineurin/NFAT-induced up-regulation of the Fas ligand/Fas death pathway is involved in methamphetamine-induced neuronal apoptosis
S Jayanthi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
ER stress and the unfolded protein response
M Schröder et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2005)
Microglial activation precedes dopamine terminal pathology in methamphetamine-induced neurotoxicity
MJ LaVoie et al.
EXPERIMENTAL NEUROLOGY (2004)
Optimal delivery of minocycline to the brain: implication for human studies of acute neuroprotection
SC Fagan et al.
EXPERIMENTAL NEUROLOGY (2004)
Role of tumor necrosis factor-α in methamphetamine-induced drug dependence and neurotoxicity
A Nakajima et al.
JOURNAL OF NEUROSCIENCE (2004)
Cannabinoids and neuroinflammation
L Walter et al.
BRITISH JOURNAL OF PHARMACOLOGY (2004)
Methamphetamine induces neuronal apoptosis via cross-talks between endoplasmic reticulum and mitochondria-dependent death cascades
S Jayanthi et al.
FASEB JOURNAL (2004)
Neurotoxic morphological changes induced in the medial prefrontal cortex of rats behaviorally sensitized to methamphetamine
T Kadota et al.
ARCHIVES OF HISTOLOGY AND CYTOLOGY (2004)
High-dose methamphetamine acutely activates the striatonigral pathway to increase striatal glutamate and mediate long-term dopamine toxicity
KA Mark et al.
JOURNAL OF NEUROSCIENCE (2004)
Lentiviral vector delivery of parkin prevents dopaminergic degeneration in an α-synuclein rat model of Parkinson's disease
C Lo Bianco et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
The promise of minocycline in neurology
VW Yong et al.
LANCET NEUROLOGY (2004)
Neuroprotection by tetracyclines
M Domercq et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2004)
Minocycline: Neuroprotective mechanisms in Parkinson's disease
M Thomas et al.
CURRENT PHARMACEUTICAL DESIGN (2004)
Methamphetamine neurotoxicity in dopamine nerve endings of the striatum is associated with microglial activation
DM Thomas et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
Histological evidence supporting a role for the striatal neurokinin-1 receptor in methamphetamine-induced neurotoxicity in the mouse brain
J Yu et al.
BRAIN RESEARCH (2004)
Altered action of dopamine and cholecystokinin on lateral hypothalamic neurons in rats raised under different feeding conditions
U Zippel et al.
BEHAVIOURAL BRAIN RESEARCH (2003)
Increased human immunodeficiency virus loads in active methamphetamine users are explained by reduced effectiveness of antiretroviral therapy
RJ Ellis et al.
JOURNAL OF INFECTIOUS DISEASES (2003)
Methamphetamine-induced neurotoxicity in mouse brain is attenuated by ketoprofen, a non-steroidal anti-inflammatory drug
M Asanuma et al.
NEUROSCIENCE LETTERS (2003)
Speed kills: cellular and molecular bases of methamphetamine-induced nerve terminal degeneration and neuronal apoptosis
JL Cadet et al.
FASEB JOURNAL (2003)
HIV-1 protein Tat potentiation of methamphetamine-induced decreases in evoked overflow of dopamine in the striatum of the rat
WA Cass et al.
BRAIN RESEARCH (2003)
Minocycline inhibits caspase-independent and -dependent mitochondrial cell death pathways in models of Huntington's disease
X Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Liquid chromatographic determination of minocycline in brain-to-plasma distribution studies in the rat
M Colovic et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2003)
Proteomic identification of nitrated proteins in Alzheimer's disease brain
A Castegna et al.
JOURNAL OF NEUROCHEMISTRY (2003)
Cholecystokinin combined with serotonin in the hypothalamus limits accumbens dopamine release while increasing acetylcholine: a possible satiation mechanism
KA Helm et al.
BRAIN RESEARCH (2003)
Methamphetamine potentiates HIV-1 Tat protein-mediated activation of redox-sensitive pathways in discrete regions of the brain
G Flora et al.
EXPERIMENTAL NEUROLOGY (2003)
The p53-activated gene, PAG608, requires a zinc finger domain for nuclear localization and oxidative stress-induced
Y Higashi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Methamphetamine-induced increase in striatal p53 DNA-binding activity is attenuated in Cu,Zn-superoxide dismutase transgenic mice
M Asanuma et al.
NEUROSCIENCE LETTERS (2002)
Chronic methamphetamine exposure alters immune function in normal and retrovirus-infected mice
QL Yu et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2002)
Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice
S Zhu et al.
NATURE (2002)
Motivations associated with methamphetamine use among HIV plus men who have sex with men
SJ Semple et al.
JOURNAL OF SUBSTANCE ABUSE TREATMENT (2002)
Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease
YS Du et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers
ND Volkow et al.
AMERICAN JOURNAL OF PSYCHIATRY (2001)
Gadd153 sensitizes cells to endoplasmic reticulum stress by down-regulating Bc12 and perturbing the cellular redox state
KD McCullough et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
Parkin functions as an E2-dependent ubiquitin-protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1
Y Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Neurotoxicity of HIV-1 proteins gp120 and Tat in the rat striatum
AK Bansal et al.
BRAIN RESEARCH (2000)
Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase
H Shimura et al.
NATURE GENETICS (2000)
Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease
M Chen et al.
NATURE MEDICINE (2000)
Protein nitration, metabolites of reactive nitrogen species, and inflammation in lung allografts
JA De Andrade et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2000)
History of the methamphetamine problem
MD Anglin et al.
JOURNAL OF PSYCHOACTIVE DRUGS (2000)
HIV-1 Tat-mediated inhibition of the tyrosine hydroxylase gene expression in dopaminergic neuronal cells
G Zauli et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Methamphetamine-induced striatal dopamine neurotoxicity and cyclooxygenase-2 protein expression in BALB/c mice
T Kita et al.
NEUROPHARMACOLOGY (2000)
分享论文
